A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a company-funded study. The study was ...

The LNP-mRNA modality is a novel approach that ... Immunogenicity testing focuses on detecting small amounts of antidrug antibodies, so assay sensitivity needs to be carefully determined.

On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson's disease in Q4 2025Strengthened balance sheet with recent financingAdvancing innovative POZ Platform acro ...

Mana.bio, a biotechnology company leveraging artificial intelligence (AI) and nanotechnology for targeted RNA delivery, today announced three poster presentations at the American Society of Gene & ...

Beam Therapeutics Inc.’s BEAM share price has surged by 7.36%, which has investors questioning if this is right time to sell.

Advancing innovative POZ Platform across multiple therapeutic modalities Two new seasoned biotech leaders added to the Board of Directors HUNTSVILLE, May 08, 2025 (GLOBE NEWSWIRE) -- Serina ...

Serina’s POZ PlatformTM provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced that it was awarded a ?10 million grant from EU4Health, the EU's largest ...

Donald Trump has delivered a humiliating takedown of Peter Dutton as Anthony Albanese tells opponents to 'get out of the way'. Plus, who will be the next leader of the opposition?